Revolutionizing Diagnostics and Advancing Life Sciences Innovation from Early-Phase Research to Clinical Applications: Revvity Unveils State-of-the-Art Solutions at SLAS2024
Unveiling the New Brand: Making its debut at SLAS, Revvity introduces its fresh brand, emphasizing the ongoing commitment to pushing the boundaries of human potential through scientific innovation. The revitalized company showcases a range of specialized technologies and expertise geared…
SCIEX Enhances High-Throughput Screening Solutions through Introduction of Echo® MS+ System
SCIEX, a renowned global provider of analytical technologies in the life sciences, has unveiled the Echo® MS+ system during SLAS 2024. This cutting-edge system integrates the proprietary Acoustic Ejection Mass Spectrometry technology with Open Port Interface (OPI) sampling, leveraging the…
MedImpact Enhances Its Reach with the Acquisition of Elixir Solutions
Solidifying its standing as the premier independent provider of health solutions, technology, and pharmacy benefit management, MedImpact expands through strategic acquisition MedImpact Healthcare Systems, Inc., the largest independent provider of health solutions, technology, and pharmacy benefit management in the nation,…
Hologic Introduces Genius™ Digital Diagnostics System, the First and Sole FDA-Cleared Digital Cytology System
everaging Advanced Imaging and Innovative Artificial Intelligence, the Latest Diagnostic System Enhances Cervical Cancer Screening Accuracy, Workflow Efficiency, and Patient Care Hologic, Inc. (Nasdaq: HOLX) has announced that its groundbreaking Genius™ Digital Diagnostics System, featuring the Genius™ Cervical AI algorithm,…
Longboard Pharmaceuticals Discloses Inducement Grants in Accordance with Nasdaq Listing Rule 5635(C)(4)
Longboard Pharmaceuticals, a clinical-stage biopharmaceutical company dedicated to pioneering transformative medicines for neurological diseases, has officially granted inducement awards to five new employees. The Compensation Committee of the Board of Directors at Longboard has approved non-qualified stock options, totaling 145,475…
Napp Secures Approval for REZZAYO® from the UK Medicines and Healthcare Products Regulatory Agency for Treating Invasive Candidiasis in Adults.
For Exclusive Distribution to GB Trade and Medical Media REZZAYO® (rezafungin) is approved for treating invasive candidiasis in adults. Adherence to official guidelines regarding the appropriate use of antifungal agents is recommended.2 The marketing authorization stems from favorable outcomes in…
Takeda Unveils Succession Plan for Chief Financial Officer Role
Takeda’s Chief Financial Officer Costa Saroukos Announces Departure; Milano Furuta to Assume Role Effective April 1, 2024 TOKYO, Japan — In an announcement today, Takeda disclosed that Costa Saroukos, the current Chief Financial Officer, has made the decision to resign…
Atara Biotherapeutics and Pierre Fabre Laboratories Release Phase 3 ALLELE Tab-cel® Data in The Lancet Oncology
Atara Biotherapeutics and Pierre Fabre Laboratories Publish Data from Phase 3 ALLELE Tab-cel® Trial in The Lancet Oncology” Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, and Pierre Fabre Laboratories, a global player in oncology responsible for the…
Solidsoft Reply Takes Charge of the Migration for Finland’s National Drug Verification System
Solidsoft Reply, a subsidiary of the Reply Group specializing in crafting business solutions on the Microsoft Azure cloud, has successfully migrated Finland’s National Medicines Verification System to its National Blueprint solution. Designed to comply with the EU Falsified Medicines Directive…
Kindeva Drug Delivery Establishes New Global Business Unit for Analytical Services
Kindeva Drug Delivery (Kindeva), a prominent player in drug and medical device combination products globally, has unveiled the expansion of its analytical services, establishing a new global business unit. This unit is dedicated to providing integrated and standalone analytical support…
Ally Health Collaborates with Acacium Group to Transform Technology-Enabled Clinical Care at Home
Pioneering health tech platform Ally Health and leading global healthcare delivery partner Acacium Group have joined forces in a new partnership aimed at revolutionizing the delivery of community care. With over 70% of medical decisions requiring follow-up appointments, Ally Health’s…
Align Technology Ranks Among the Top 300 Global Organizations Awarded U.S. Patents in 2023
Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company specializing in the design, manufacturing, and sale of the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, proudly announces…